Nuzenio

Tradingview Vir Biotechnology

Tradingview Vir Biotechnology entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Vir Biotechnology, Inc. Stock 12‑Month Price Target Cut to $21.33, Implies 134% Upside - TradingViewTradingView · Thu, 06 Aug 2026 07:20:14 GMTVir Biotechnology Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 07:03:58 GMTVIR: Q2 2026 saw major revenue gains, clinical milestones, and a strengthened cash position to $1.01B - TradingViewTradingView · Wed, 05 Aug 2026 22:09:41 GMTVir Biotechnology 2Q 2026: Revenue $238.95M, Net income $80.08M, EPS $0.47— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:31:01 GMTVir Biotechnology Q2 revenue up, beats estimates on Astellas payment - TradingViewTradingView · Wed, 05 Aug 2026 20:20:40 GMTVir Biotechnology posts $238.9M Q2 revenue, $80.1M net income; $1.01B cash runway into H2 2028 - TradingViewTradingView · Wed, 05 Aug 2026 20:13:01 GMTVIR Q2'26 Earnings: EPS estimate is 0.33 USD - TradingViewTradingView · Tue, 04 Aug 2026 11:01:07 GMT

Timeline

Thu, 06 Aug 2026 07:20:14 GMTVir Biotechnology, Inc. Stock 12‑Month Price Target Cut to $21.33, Implies 134% Upside - TradingView
Thu, 06 Aug 2026 07:03:58 GMTVir Biotechnology Q2 Earnings Call Highlights - TradingView
Wed, 05 Aug 2026 22:09:41 GMTVIR: Q2 2026 saw major revenue gains, clinical milestones, and a strengthened cash position to $1.01B - TradingView
Wed, 05 Aug 2026 21:31:01 GMTVir Biotechnology 2Q 2026: Revenue $238.95M, Net income $80.08M, EPS $0.47— 10-Q Summary - TradingView
Wed, 05 Aug 2026 20:20:40 GMTVir Biotechnology Q2 revenue up, beats estimates on Astellas payment - TradingView
Wed, 05 Aug 2026 20:13:01 GMTVir Biotechnology posts $238.9M Q2 revenue, $80.1M net income; $1.01B cash runway into H2 2028 - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Vir Biotechnology.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.